IBS

Rifaximin May Improve Abdominal Pain Symptoms in IBS-D

Rifaximin May Improve Abdominal Pain Symptoms in IBS-D

By

A 2-week course of treatment with rifaximin for diarrhea-predominant irritable bowel syndrome was found to improve abdominal pain symptoms.

FDA to Review Trulance for IBS With Constipation in Adults

FDA to Review Trulance for IBS With Constipation in Adults

By

The FDA has accepted the supplemental New Drug Application for Trulance for the treatment of irritable bowel syndrome with constipation.

Stress, the Microbiota and Visceral Pain

Stress, the Microbiota and Visceral Pain

A high proportion of individuals with IBS have comorbid anxiety and depression affecting the HPA axis and microbiota.

Sign Up for Free e-Newsletters